Lorvotuzumab mertansine
| Lorvotuzumab mertansine | |
|---|---|
| Term | Lorvotuzumab mertansine |
| Short definition | lorvotuzumab mertansine (LOR-voh-TOO-zoo-mab mer-TAN-seen) A substance being studied to treat some types of cancer, including Wilms' tumor, neuroblastoma, rhabdomyosarcoma, and other types of soft tissue sarcomas. Lorvotuzumab mertansine contains a monoclonal antibody that attaches to a protein called CD56 on some types of cancer cells. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
lorvotuzumab mertansine - (pronounced) (LOR-voh-TOO-zoo-mab mer-TAN-seen) A substance being studied to treat some types of cancer, including Wilms' tumor, neuroblastoma, rhabdomyosarcoma, and other types of soft tissue sarcomas. Lorvotuzumab mertansine contains a monoclonal antibody that attaches to a protein called CD56 on some types of cancer cells. It also contains a cancer drug called DM1, which can help kill cancer cells after lorvotuzumab mertansine binds to them. Lorvotuzumab mertansine is a type of antibody-drug conjugate. Also called BB-10901
External links
- Medical encyclopedia article on Lorvotuzumab mertansine
- Wikipedia's article - Lorvotuzumab mertansine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski